Martingale Asset Management’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $349K | Buy |
+30,386
| New | +$401K | 0.01% | 709 |
|
|
2023
Q1 | – | Sell |
-16,574
| Closed | -$340K | – | 876 |
|
|
2022
Q4 | $340K | Sell |
16,574
-2,400
| -13% | -$42.3K | 0.01% | 697 |
|
|
2022
Q3 | $364K | Sell |
18,974
-31,499
| -62% | -$708K | 0.01% | 685 |
|
|
2022
Q2 | $1.19M | Buy |
50,473
+622
| +1% | +$17.8K | 0.02% | 410 |
|
|
2022
Q1 | $1.63M | Sell |
49,851
-4,405
| -8% | -$142K | 0.02% | 351 |
|
|
2021
Q4 | $1.69M | Buy |
54,256
+2,309
| +4% | +$77.2K | 0.02% | 353 |
|
|
2021
Q3 | $1.98M | Buy |
51,947
+13,102
| +34% | +$522K | 0.03% | 308 |
|
|
2021
Q2 | $1.56M | Buy |
38,845
+905
| +2% | +$38.2K | 0.02% | 300 |
|
|
2021
Q1 | $1.65M | Sell |
37,940
-199
| -0.5% | -$8.77K | 0.02% | 316 |
|
|
2020
Q4 | $1.64M | Sell |
38,139
-51,597
| -57% | -$1.88M | 0.02% | 315 |
|
|
2020
Q3 | $2.79M | Sell |
89,736
-51,196
| -36% | -$1.59M | 0.03% | 337 |
|
|
2020
Q2 | $4.51M | Buy |
140,932
+3,201
| +2% | +$106K | 0.05% | 335 |
|
|
2020
Q1 | $3.86M | Buy |
137,731
+4,600
| +3% | +$178K | 0.05% | 351 |
|
|
2019
Q4 | $6.15M | Buy |
133,131
+6,801
| +5% | +$320K | 0.06% | 328 |
|
|
2019
Q3 | $6.7M | Buy |
126,330
+14,403
| +13% | +$743K | 0.07% | 315 |
|
|
2019
Q2 | $5.92M | Buy |
111,927
+4,502
| +4% | +$239K | 0.06% | 326 |
|
|
2019
Q1 | $6.06M | Buy |
107,425
+11,094
| +12% | +$623K | 0.07% | 312 |
|
|
2018
Q4 | $5.06M | Buy |
96,331
+19,704
| +26% | +$1.12M | 0.07% | 314 |
|
|
2018
Q3 | $4.43M | Buy |
76,627
+15,602
| +26% | +$874K | 0.05% | 342 |
|
|
2018
Q2 | $3.47M | Buy |
61,025
+1,001
| +2% | +$57K | 0.04% | 404 |
|
|
2018
Q1 | $3.53M | Sell |
60,024
-2,900
| -5% | -$162K | 0.05% | 386 |
|
|
2017
Q4 | $3.44M | Sell |
62,924
-7,098
| -10% | -$368K | 0.05% | 389 |
|
|
2017
Q3 | $3.31M | Sell |
70,022
-2
| -0% | -$94 | 0.04% | 430 |
|
|
2017
Q2 | $3.25M | Sell |
70,024
-2
| -0% | -$83 | 0.05% | 413 |
|
|
2017
Q1 | $2.67M | Hold |
70,026
| – | – | 0.04% | 466 |
|
|
2016
Q4 | $2.53M | Sell |
70,026
-2,161
| -3% | -$82K | 0.04% | 480 |
|
|
2016
Q3 | $3.09M | Buy |
72,187
+36,518
| +102% | +$1.63M | 0.05% | 399 |
|
|
2016
Q2 | $1.51M | Sell |
35,669
-4,057
| -10% | -$176K | 0.03% | 381 |
|
|
2016
Q1 | $1.65M | Buy |
39,726
+9,658
| +32% | +$379K | 0.03% | 359 |
|
|
2015
Q4 | $1.18M | Sell |
30,068
-7,801
| -21% | -$291K | 0.03% | 428 |
|
|
2015
Q3 | $1.28M | Sell |
37,869
-10,103
| -21% | -$360K | 0.03% | 395 |
|
|
2015
Q2 | $1.59M | Hold |
47,972
| – | – | 0.04% | 367 |
|
|
2015
Q1 | $1.72M | Sell |
47,972
-3,400
| -7% | -$107K | 0.04% | 358 |
|
|
2014
Q4 | $1.54M | Sell |
51,372
-87
| -0.2% | -$2.55K | 0.04% | 379 |
|
|
2014
Q3 | $1.59M | Buy |
51,459
+15,209
| +42% | +$505K | 0.05% | 347 |
|
|
2014
Q2 | $1.31M | Buy |
+36,250
| New | +$1.17M | 0.04% | 424 |
|
Other funds holding OFIX
ECM
JIC
RCMNY
PCMI
AC
VCM
Martingale Asset Management's OFIX Position: Q1 2026 in Review
Martingale Asset Management opened a new position in Orthofix Medical (OFIX) in Q1 2026: 30,386 shares worth $349K. The stake represents 0.01% of the portfolio and ranks #709 among its holdings. This is a return to the name: Martingale Asset Management previously reported a position in OFIX as recently as Q4 2022.
Martingale Asset Management first reported a position in OFIX in Q2 2014 and has held it in 36 quarters since. The position peaked at $6.7M in Q3 2019. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.
- Martingale Asset Management held 30,386 shares of Orthofix Medical worth $349K as of Q1 2026.
- Orthofix Medical was a new Martingale Asset Management position in Q1 2026.
- Orthofix Medical made up 0.01% of Martingale Asset Management's portfolio in Q1 2026, its #709 holding.
- Martingale Asset Management first reported a position in Orthofix Medical in Q2 2014 and has held it in 36 quarters since.
- Martingale Asset Management's Orthofix Medical position peaked at $6.7M in Q3 2019.
- 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.